| Literature DB >> 25025028 |
Joo Dong Kim1, Dong Lak Choi1, Young Seok Han1.
Abstract
Extensive thrombosis of the portal and splenomesenteric veins combined with cavernous transformation of the portal vein (CTPV) has been considered to be a contraindication for living donor liver transplantation (LDLT) due to technical difficulties and perioperative risks. In recent years, several surgical innovations including cavoportal hemitransposition, renoportal anastomosis, and portal arterialization have been introduced to overcome diffuse portal vein thrombosis (PVT) and CTPV, but their outcomes were unsatisfactory with significant morbidity and mortality. Herein, we report two successful cases of adult LDLT in diffuse PVT with CTPV managed using the paracholedochal vein as portal inflow to the graft.Entities:
Keywords: Cavernous transformation of portal vein; Liver transplantation; Living donors
Year: 2014 PMID: 25025028 PMCID: PMC4091443 DOI: 10.4174/astr.2014.87.1.47
Source DB: PubMed Journal: Ann Surg Treat Res ISSN: 2288-6575 Impact factor: 1.859
Fig. 1(A) Preoperative CT showed diffuse portal vein thrombosis (arrow) extended to superior mesenteric vein (SMV) and marked dilated paracholedochal veins (arrowhead). (B) Schematic illustration of cavernous transformation of the portal vein found at CT and mesenteric venography showed large tortuous paracholedochal collaterals (arrows) and complete invisibility of main portal vein and proximal SMV due to thrombosis. PV, portal vein; SV, splenic vein; GEV, gastroepiploic vein.
Fig. 2(A) End-to-end portal anastomosis was constructed between the graft and common cloaca formed by the confluence of paracholedochal veins (arrowhead). (B) Good portal vein patency to the graft (arrow) was demonstrated by dynamic computed tomography on the 14th postoperative day.
Fig. 3(A) The complex common orifice formed by venoplasty from paracholedochal collaterals and native portal vein was anastomosed to the donor portal vein (arrowhead). (B) Serial postoperative Doppler studies demonstrated satisfactory portal vein flow to the graft.